Jun 22, 2015
Big
pharma is making a comeback with cutting edge new drugs to do
battle with alzheimers, diabetes, various forms of vaccines,
oncology, and acute hospital care. Meanwhile, the Food and
Drug Administration has speeded approval of drugs. The agency
approved 41 new drugs last year, the most in 18 years, and well
above the average of 25 per year since 2005.